Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement

Part of paid clinical trials in Addison, Illinois.

Sponsor
Shaklee Corporation
Study ID
NCT07428889
Status
Recruiting
Apply to this trial

Conditions

  • Healthy Adult

Eligibility Criteria

Sex
ALL
Age
45 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • Proprietary Nutritional Supplement — DIETARY_SUPPLEMENT
    1000 mg nicotinamide metabolites and plant extracts, taken orally, daily for 60 days
  • Placebo Supplement — DIETARY_SUPPLEMENT
    1000 mg maltodextrin, taken orally, daily for 60 days

Study Details

The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+) in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo.

Key Dates

Start date
Feb 17, 2026
Status verified
Feb 2026
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
34 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Proprietary nutritional supplement
    Participants will take the experimental supplement orally, daily.
  • Placebo Comparator: Placebo supplement
    Participants will take the placebo supplement orally, daily.

Primary Outcome Measure

Nicotinamide adenine dinucleotide response in whole blood [ Time Frame: Baseline to Day 14 ]

Central Contacts

  • Biofortis Research Clinical Director Biofortis Research Clinical Director
    (630) 617-2000
    [email protected]

Locations (1)

FacilityCityStateZIPSite coordinators
Biofortis Clinical ResearchAddisonIllinois60101
Biofortis Research Clinical Director
[email protected]
Aditi Shah (PRINCIPAL_INVESTIGATOR)

Find similar trials in Addison, IL

By research site
Biofortis Clinical Research· Addison, IL

Related Studies